|

Apixaban 2.5 MG PO BID Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • National Institute of Cardiovascular Diseases, Pakistan1

Indications

  • Prophylaxis1
  • Acute Myocardial Infarction of Anterior Wall1
  • Left Ventricular Thrombus1
  • Heart Disease1

Other1 trial

Apixaban Prophylaxis for Prevention of Left Ventricular Thrombus Following Anterior Myocardial Infarction
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.